MENLO PARK, Calif., Aug. 26, 2015 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback